Asset-backed finance and life sciences direct lending are just two branches of growth within private credit, as leading firms such as Oaktree Capital Management look to tap in to a golden period for the asset class; one that has grown to $1.5 trillion. As banks retrench, it is creating dislocation opportunities for savvy investors in shipping, aviation and manufacturing equipment; potentially offering a golden ticket to support transport operators. Unfortunately, there were no chocolate factories available at the time of writing. Lending to life science companies is also an investment theme according to Armen Panossian, who will become Oaktree’s co-CEO in the New Year. As we enter the festive season, private credit investors have plenty to celebrate. The search for the next golden ticket is on!